Sort   by:  
 Page size 
UnknownIn-depth characterization of NK cell markers from CML patients who discontinued tyrosine kinase inhibitor therapy.
Not available
S-EPMC10561287 | biostudies-literature
UnknownElevated plasma levels of IL-6 and MCP-1 selectively identify CML patients who better sustain molecular remission after TKI withdrawal.
Not available
S-EPMC10148988 | biostudies-literature
UnknownVenetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia.
Not available
S-EPMC10067719 | biostudies-literature
UnknownEvaluation of the primitive fraction by functional in vitro assays at the RNA and DNA level represents a novel tool for complementing molecular monitoring in chronic myeloid leukemia.
Not available
S-EPMC5945542 | biostudies-literature
UnknownmiRNome profiling of LSC-enriched CD34+CD38-CD26+ fraction in Ph+ CML-CP samples from Argentinean patients: a potential new pharmacogenomic tool.
Not available
S-EPMC7869017 | biostudies-literature
Sort   by:  
 Page size